Evidence map›Paper›PMID 42142183›Full record

ArticleEuropean journal of applied physiology2026

A speed-oriented phenotype is beneficial for 1500 m rowing at the Los Angeles 2028 Olympic Games.

Erik Baumann, Emma M C van der Vorst, Mathijs J Hofmijster

Abstract read
In one paragraph

Article in European journal of applied physiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Erik BaumannFaculty of Behavioural and Movement Sciences, Vrije Universiteit, Amsterdam, The Netherlands. erikbaumann23@gmail.com.ORCID http://orcid.org/0009-0008-3672-6635
Emma M C van der VorstFaculty of Behavioural and Movement Sciences, Vrije Universiteit, Amsterdam, The Netherlands.ORCID http://orcid.org/0009-0000-5339-1808
Mathijs J HofmijsterFaculty of Behavioural and Movement Sciences, Vrije Universiteit, Amsterdam, The Netherlands.ORCID http://orcid.org/0000-0002-8377-9413

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe shorter rowing course at the Los Angeles 2028 Olympics, which is 1500 m instead of 2000 m, potentially alters the physiological demands of racing. This study aims to elucidate whether the shortened distance favours rowers with a more speed-oriented phenotype, using two non-invasive profiling approaches: locomotor profiling and force-velocity (F-v) profiling.

methodsNine nationally competitive male rowers completed 2000 m and 1500 m rowing ergometer time trials. Peak power tests and graded exercise tests were used to determine the athletes' locomotor profiles expressed as Power Reserve Ratio (PRR) and loaded back squat testing was performed to establish individual F-v profiles. Relative performance was expressed as the ratio between mean power output of the 1500 m and 2000 m time trials (MPO

resultsPRR showed a strong positive correlation with MPO

conclusionTogether, these findings support the notion that the shortened Olympic rowing distance places greater emphasis on speed -ability, a challenge that suits athletes leaning towards a more speed-oriented phenotype. While aerobic capacity remains essential in 1500 m rowing, subtle adjustments in athlete selection and training toward increased anaerobic and explosive qualities may optimize performance at the Los Angeles 2028 Olympics.

Indexed as

Athletic PerformanceWater SportsAdultAthletesExercise TestHumansLos AngelesMalePhenotypeEndurance sportExercise physiologyForce-velocity profilingLocomotor profilingRowing performance

Identifiers

PMID42142183
PMCPMC13451562

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.